Patients with a cardiac complete response in AL amyloidosis have survival rates similar to those of a matched general population
Eli Muchtar, Susan Geyer, Giampaolo Merlini, Morie A. Gertz
Abstract
ABSTRACT: The survival of patients achieving a cardiac complete response in light chain amyloidosis, defined as N-terminal pro B-type natriuretic peptide ≤350 pg/mL or B-type natriuretic peptide ≤80 pg/mL, was similar to that of a matched general population, with estimated 5-year survival rates of 93% and 95%, respectively.
Topics & Concepts
AL amyloidosisInternal medicineCardiac amyloidosisPopulationMedicineAmyloidosisCardiologySurvival rateImmunologyAntibodyEnvironmental healthImmunoglobulin light chainAmyloidosis: Diagnosis, Treatment, OutcomesLanthanide and Transition Metal ComplexesParathyroid Disorders and Treatments